Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Hikma Ventures

Profile and portfolio

Parent Hikma PharmaceuticalsHQ Amman, JordanFounded 2015

Hikma Ventures is the corporate venture arm of Hikma Pharmaceuticals, a pharmaceutical and biotech company. It was founded in 2015 and is based in Amman, Jordan. It invests from Series A to Series C+. Sectors it names: healthcare and digital health, biotech and life sciences.

Companies backedS3
18
ExitsS3
6

Every figure links to its source

Snapshot

Investment stage: Series A to Series C+
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series C+
SectorsHealthcare and digital health, Biotech and life sciences
GeographyGlobal
OfficesAmman, Jordan

Sources: S4 Hikma Ventures about; S1 Hikma Ventures.

Graphic 1 of 2

Investment stage: Series A to Series C+

Sources: S4 Hikma Ventures about; S1 Hikma Ventures.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Companies backed18companiesStated by the firmS3
Exits6exitsStated by the firmS3
Companies on the firm's portfolio page18companiesCounted from the firm's own listS3

Sources: S3 Hikma Ventures portfolio.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S3 Hikma Ventures portfolio.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Amman, Jordan

Investment regionsS4S1

LeadersS2

Hikma Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companyHikma Pharmaceuticals (LSE: HIK)Single sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2015Single sourceS1
HeadquartersAmman, JordanSingle sourceS5
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Companies backed18Single sourceS3
Exits6 totalSingle sourceS3
StagesSeries A, Series B, Series C+Single sourceS4

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeAcquirer or exchangeSource
LemonaidAcquisition23andMeS3
Nebula GenomicsAcquisitionProPhase LabsS3
PilloAcquisitionStanley Black and DeckerS3
PropellerAcquisitionResMedS3
Tact.aiAcquisitionAktanaS3
WinterlightAcquisitionCambridge CognitionS3

Portfolio

The firm's portfolio page lists 18 companies.S3

Shared portfolio with other corporate VCs

7 companies on the Hikma Ventures portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
M Ventures2Altoida, Biolinq
Echo Health Ventures1Octave
Intermountain Ventures1Octave
Merck Global Health Innovation Fund1Octave
M121Tact.ai
Salesforce Ventures1Tact.ai
Sony Innovation Fund1Activ Surgical
Sanofi Ventures1Click Therapeutics
GIS Strategic Ventures1Prognos

Companies backed by the most corporate VCs

Every company on the Hikma Ventures list

18 companies, as listed on the firm's own website: 12 listed, 6 exited.S3 Read the firm's list.

Listed 12

  • Activ Surgical
  • Altibbi
  • Altoida
  • Biolinq
  • Click Therapeutics
  • I2 Therapeutics
  • Lightship
  • Nuvoair
  • O7 Therapeutics
  • Octave
  • Prognos
  • SeamlessMD

Exited 6

  • Lemonaid
  • Nebula Genomics
  • Pillo
  • Propeller
  • Tact.ai
  • Winterlight

History

  1. Hikma Ventures established.S1

About Hikma Pharmaceuticals

ItemDetailSource
Listed asLSE: HIKS1
HeadquartersUnited KingdomS1

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Hikma VenturesFirm
  2. S2Hikma Ventures teamFirm
  3. S3Hikma Ventures portfolioFirm
  4. S4Hikma Ventures aboutFirm
  5. S5Wamda: Hikma Pharmaceuticals launches $30M digital health venture fund in Amman (Apr 2016)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Hikma Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.